AMPlify – Accelerated US Market Entry for Finnish Healthcare Companies

AMPlify is a curated, high-impact collaboration platform designed to support Finnish healthcare, health tech, and diagnostic companies in accelerating and building their readiness for the U.S. healthcare market, the world’s largest and most complex ecosystem. Expanding upon the successful Nordic AMPlify and Gazelle programs, AMPlify is a complete ecosystem that brings together Finnish companies and one of the world’s leading health systems, Mayo Clinic. AMPlify offers a structured pathway of expert-led workshops, mentorship, investor insights, and practical guidance to fast-track successful U.S. market entry.

The US market represents 40% of the global healthcare market, and more than 30% of new technologies are joint ventures with non-US entities. American health systems are transforming their innovation centers into international co-development ventures. Through AMPlify, Mayo Clinic has identified Finland as a strategic focus area.

Mayo Clinic continuously seeks to improve quality of care, operational efficiencies, and patient outcomes across the full continuum of care and care management. Achieving this requires constant innovation, particularly in areas that improve clinical operations, reduce system-wide costs, and enable scalable care delivery. Working with external companies through structured platforms is a proven pathway, and the demand for advanced digital, automated, and data-driven solutions is both real and urgent.

AMPlify provides Finnish companies with a strategic and competitive advantage by combining U.S. healthcare expertise with direct access to local champions, key opinion leaders, decision-makers, and collaboration pathways.

The platform features a carefully designed curriculum of workshops, one-on-one mentoring, and webinars with leading U.S. healthcare providers, investors, strategic partners, and Mayo Clinic experts. Participating companies gain the tools, feedback, and connections needed to refine their value proposition, understand regulatory and reimbursement dynamics, engage U.S. stakeholders, and develop scalable collaboration and commercialization pathways.

Who Should Apply
AMPlify is designed for Finnish companies that are serious about engaging with the U.S. healthcare ecosystem through a structured collaboration platform. The program is suitable for early-stage to growth-stage companies developing solutions in digital health, medical technologies, diagnostics, or biopharma, addressing meaningful challenges in clinical operations, care delivery, and healthcare infrastructure.

Especially companies focused on:

• Robotics and automation, e.g., SPD-related solutions
• Automation of large-scale pharmacy operations, including compounding, dispensing, and medication workflow optimization
• Biopharma and diagnostics, with a strong preference for deep, novel technologies, such as advanced biopharma platforms and next-generation diagnostic solutions
• Operational efficiencies
• Quality improvements to the standards of care, and more

Program Structure

• Virtual program introduction: February 24, 2026
• Application Period: February-March 30, 2026
• Cohort Selection: Announced in May 2026
• In-Person Kickoff: Helsinki, June 2026
• One-on-One mentoring: Each company will receive two individual mentoring sessions (60–90 minutes each)
• Workshops & Webinars: Virtual bi-weekly sessions from July to October, 2026
• U.S. Market Visit: On-site visit to Mayo Clinic, Rochester, Minnesota, in November 2026
• Participation Fee: EUR 6,000 (travel expenses to Rochester not included)